IL10 and diffuse large B-cell lymphoma: The other polymorphisms, as well as the presence or absence of the haplotype ACC of IL10, had no impact on the clinical evolution of DLBCL based on global and progression-free survival, as well as on the therapeutic response in the univariate and multivariate Cox analyses.